Stf Management LP Amgen Inc Transaction History

Stf Management LP

$208 Billion
Q1 2025

A detailed history of Stf Management LP transactions in Amgen Inc stock. As of the latest transaction made, Stf Management LP holds 8,037 shares of AMGN stock, worth $2.36 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

8,037

Previous 8,051 0.17%

Holding current value

$2.36 Million

Previous $2.1 Billion 19.32%

% of portfolio

1.2%

Previous 0.94%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$258.59 - $327.36 $3,620 - $4,583	-14 Reduced 0.17%	8,037 $2.5 Billion
Q4 2024 Feb 12, 2025	BUY	$258.78 - $328.31 $55,896 - $70,914	216 Added 2.76%	8,051 $2.1 Billion
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $221,516 - $241,564	-716 Reduced 8.37%	7,835 $2.52 Billion
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $109,566 - $133,152	-417 Reduced 4.65%	8,551 $2.67 Billion
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $18,014 - $21,745	-67 Reduced 0.74%	8,968 $2.55 Billion
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $74,664 - $84,230	292 Added 3.34%	9,035 $2.6 Billion
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $1.18 Million - $1.46 Million	5,395 Added 161.14%	8,743 $2.35 Billion
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $617,740 - $730,465	-2,883 Reduced 46.27%	3,348 $743 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $604,214 - $736,435	2,676 Added 75.27%	6,231 $1.51 Billion
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $814,201 - $1.03 Million	3,555 New	3,555 $934 Million

Others Institutions Holding AMGN

# of Institutions

3,309

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stf Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stf Management LP with notifications on news.

Account

Stf Management LP Amgen Inc Transaction History